PHILIP CREPS: Open Payments
NPI 1649284688 · GARDENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,029 in 36 payments from 9 companies in 2025. Trend: 2023 $534 · 2024 $900 · 2025 $1,029
Food & beverage: $829Consulting: $200
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $284 |
| Janssen Scientific Affairs, LLC | 2 | $229 |
| Janssen Pharmaceuticals, Inc | 5 | $154 |
| Otsuka America Pharmaceutical, Inc. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 2 | $77 |
| Supernus Pharmaceuticals, Inc. | 3 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $27 |
Products named: SPRAVATO, VRAYLAR, REXULTI, CAPLYTA, HETLIOZ, TRINTELLIX.
Industry payments across CA — which companies pay providers there.
